FIELD: biotechnology.
SUBSTANCE: disclosed is an anti-LILRB1 antibody or an antigen-binding fragment thereof. Also disclosed are pharmaceutical compositions containing said antibodies for inhibiting immune evasion of tumor cells and treating oncological disease. Invention also relates to a nucleic acid coding an anti-LILRB1 antibody, a recombinant expression vector and a recombinant cell containing said nucleic acid, a method of producing an anti-LILRB1 antibody.
EFFECT: invention provides antibodies against LILRB1, having high specificity in relation to LILRB1.
12 cl, 5 dwg, 22 tbl, 6 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | ANTI-LILRB1 ANTIBODY AND ITS USE | 2020 | 
										Choi, Yoon AaKim, Jung AJung, SaemLee, Ji HyunNa, KyubongKim, YeonchulKim, Han Byul | RU2801535C1 | 
							
              
                | COMPOSITION FOR PREVENTION AND TREATMENT OF SKIN DISEASE CONTAINING SUBSTANCE SPECIFICALLY BINDING WITH VIMENTINE DERIVATIVE PEPTIDE | 2018 | 
										Kim Yoon-WonPark SungmanKim Min Soo | RU2751486C1 | 
							
              
                | ANTI-HUMAN ANGIOPOIETIN-LIKE 4 PROTEIN ANTIBODIES | 2010 | 
										Sliman U. MarkGusarova ViktorijaKim Dzee Kh.Chen Gan | RU2580045C2 | 
							
              
                | ANTIBODY FOR SPECIFIC BINDING TO N-TERMINAL DOMAIN OF LYSYL-TRNA SYNTHETASE EXPOSED ON EXTRACELLULAR MEMBRANE | 2019 | 
										Kim SunghoonKwon Nam Hoon | RU2781304C1 | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBODY SPECIFICALLY BINDING WITH THE N-TERMINAL OF LYSYL-TRNA SYNTHETASE AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF DISEASES CAUSED BY CELL MIGRATION | 2018 | 
										Kwon Nam HoonLee Jin YoungKim Sunghoon | RU2749591C1 | 
							
              
                | FUSION PROTEIN COMPRISING IL-12 AND ANTI-FAP ANTIBODY, AND USE THEREOF | 2021 | 
										Kim, DonggeonRyu, SoominLee, DaheaKim, DongsuChang, JihoonLee, Byoung Chul | RU2831612C1 | 
							
              
                | ANTIBODY SPECIFICALLY BINDING TO ICAM-1 AND ITS USE | 2019 | 
										Mun, Yu RiDzhi, Gil JongJun, SangsunKim, Dzhung Sik | RU2789757C2 | 
							
              
                | C10orf54 ANTIBODIES AND USE THEREOF | 2015 | 
										Lippinkott, DzhonVan Der Khorst, Edvard Tejn, KhtunKim, Sun, YunPresta, Leonard, G.Tenissen, Yan-Villem | RU2714232C2 | 
							
              
                | ANTI-C10orf54 ANTIBODIES AND APPLICATIONS THEREOF | 2015 | 
										Lippinkott, DzhonVan Der Khorst, Edvard Tejn, KhtunKim, Sun, YunPresta, Leonard, G.Tenissen, Yan-Villem | RU2819627C1 | 
							
              
                | NEW O-SUCCINYL HOMOSERINE TRANSFERASE VARIANT AND METHOD FOR SYNTHESIS OF O-SUCCINYL HOMOSERINE USING SAID VARIANT | 2018 | 
										Kim KyungrimShim JihyunKim Hyun AhShin Yong UkLee Peter | RU2747493C1 |